FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

(MedPage Today) — The FDA approved Cleveland Diagnostics’ blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
Dubbed IsoPSA, the in vitro diagnostic kit is indicated for men ages 50…

Source link : https://www.medpagetoday.com/urology/prostatecancer/118778

Author :

Publish date : 2025-12-01 22:21:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

Corticosteroids May Boost Short-Term Survival in Pneumonia, ARDS

AI Model Outperformed Density Assessment in Stratifying Breast Cancer Risk

Related Posts

Do Women Actually Want At-Home Cervical Cancer Screening?

3D-Printed Breast Tissue; Cancer and Ultraprocessed Food; Agent Orange and Melanoma

Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke

Thrombolysis Window May Extend to 24 Hours for Non-LVO Strokes

Gabapentin Misuse Persists, Two Analyses Show

As ICE Uses Medicaid Data, Hospitals Are in a Bind Over Warning Immigrant Patients

Do Women Actually Want At-Home Cervical Cancer Screening?

3D-Printed Breast Tissue; Cancer and Ultraprocessed Food; Agent Orange and Melanoma

Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke

Thrombolysis Window May Extend to 24 Hours for Non-LVO Strokes

Gabapentin Misuse Persists, Two Analyses Show

As ICE Uses Medicaid Data, Hospitals Are in a Bind Over Warning Immigrant Patients

FDA Updates Risks in Capecitabine, Fluorouracil Labels

FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

Categories

Archives